Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-26

FDA Approved: OMVOH — Original Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved OMVOH (mirikizumab-mrkz) from Eli Lilly through an Original Biologics License Application, authorizing its marketing. This is the agency's confirma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OMVOH (MIRIKIZUMAB-MRKZ)

Snippet

ORIG AP for OMVOH (MIRIKIZUMAB-MRKZ)